The IBMS is happy to announce the appointment of David Wells as its new Chief Executive from 1 June 2021.
As Head of Pathology at NHS England, David strove to embed pathology in the heart of healthcare by supporting the adoption of digital systems, while also influencing key national health policies and government-funded initiatives.
For the past year, David has been leading NHS England’s testing response to COVID-19 – helping to boost the testing capability of the NHS from circa 200 tests per day to 140,000 tests per day.
In his work with the Institute, David has been an IBMS Council Member for the London Region, Chair of the Membership and Marketing Committee and Deputy Chair of the IBMS Special Advisory Group for Clinical Chemistry.
He also represented the IBMS on NICE diagnostic advisory panels, and various national forums, including as an observer on the Royal College of Pathologists Council and on the Parliamentary and Science Committee.
David said: “I am really excited to be joining the IBMS as Chief Executive. As a lifelong member who has worked as a biomedical scientist, it is a huge privilege for me to now lead our professional body.
“The last year has seen the profile of the IBMS and our profession raised to a level never seen before and I hope to build upon this – ensuring that our voice is consistently heard and that the Institute provides all the opportunities, support and guidance that our members need.”